VYJAXIS Trademark

Serial Number: 98673580

VYJAXIS is a trademark filed by Incyte Holdings Corporation on July 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently pending registration.

Trademark Classes

5

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

44

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

16

Class 16 - Paper Goods

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Owner Contact Info

Incyte Holdings Corporation (148 trademarks)

Wilmington, DE 19803

Entity Type: 03

Legal Representation

Attorney of Record

Frances M. Jagla

1,630 trademarks filed View all →

Correspondence Address

Frances M. Jagla Christensen O'Connor Johnson Kindness PLLC

1201 Third Avenue, Suite 3600

Seattle, WA 98101

United States

Trademark Details

Filing Date

July 30, 2024

Registration Date

Not Registered

Published for Opposition

January 21, 2025

Goods & Services

pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of auto-immune disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders

Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building

Providing medical information to healthcare providers and patients relating to oncological, viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, myeloproliferative, skeletal or chondrocyte and dermatological disorders